Individualized homoeopathic medicines in the treatment of temporomandibular joint dysfunction: A double-blind, randomized feasibility trial

Central Council for Research in Homoeopathy0 个研究点目标入组 0 人开始时间: 待定最近更新: 2024年3月4日

研究概览

暂无简介。

•1. Patients with the complaint of pain at the Temporo Mandibular joint (M26.6)
•2. Age: 18 year(s) to 75 year(s)
•3. Both sexes
•4. Not undertaking regular medicines for any other clinical conditions other than controlled diabetes mellitus, hypertension, hypothyroidism, hypertriglyceridemia and hypercholesteremia
•5. Patients suffering from additional acute diseases like acute upper respiratory tract infection, acute gastro-enteritis, acute toothache, and acute sinusitis may be enrolled after a washout period of 1 week following recovery
•6. Voluntary written informed consent

•1. Patients with self-reported serious co-morbidities like Tuberculosis, Cardiac disorders, HIV AIDS, severe immune-compromised state, Faciomaxillary cancer, and other malignancies
•2. Patients with uncontrolled diabetes mellitus, hypertension, hypothyroidism, and dyslipidemia
•3. Patient self-reporting of taking chemotherapeutic agents, immunosuppressive medicines, teratogenic drugs, and anti-coagulant medications
•3. Suffering from known severe psychiatric disorders like bipolar disorders, schizophrenia, and severe insanity.
•4. Undergone surgery related to TMJ dysfunction
•5. Pregnant and lactating mothers
•6. Not willing to give voluntary informed consent

发起方

Central Council for Research in Homoeopathy